Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126281251 | 12628125 | 1 | I | 20150425 | 20160726 | 20160808 | 20160808 | EXP | CN-DEXPHARM-20161664 | DEXCEL | YU, M.; QIAN, J.; GUO, D.; LI, L.; LIU, X. SEVERE ADVERSE REACTIONS CAUSED BY OMEPRAZOLE: A CASE REPORT. EXPERIMENTAL AND THERAPEUTIC MEDICINE 2016, V12, P1103-1106 | 61.00 | YR | A | F | Y | 0.00000 | 20160807 | OT | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126281251 | 12628125 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | DAILY DOSE: 40 MG MILLGRAM(S) EVERY DAYS | U | U | 0 | 20 | MG | TABLET | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126281251 | 12628125 | 1 | Abdominal discomfort |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126281251 | 12628125 | OT |
126281251 | 12628125 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126281251 | 12628125 | Acute kidney injury | |
126281251 | 12628125 | Anaphylactic shock | |
126281251 | 12628125 | Diarrhoea | |
126281251 | 12628125 | Electrolyte imbalance | |
126281251 | 12628125 | Metabolic acidosis | |
126281251 | 12628125 | Nausea | |
126281251 | 12628125 | Rash | |
126281251 | 12628125 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |